Alterity Therapeutics Ltd (ATH) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.056x

Based on the latest financial reports, Alterity Therapeutics Ltd (ATH) has a cash flow conversion efficiency ratio of -0.056x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.36 Million ≈ $-1.67 Million USD) by net assets (AU$42.40 Million ≈ $30.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Alterity Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Alterity Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Alterity Therapeutics Ltd for a breakdown of total debt and financial obligations.

Alterity Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alterity Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Chuwa Wool Industry Co Taiwan Ltd
TW:1439
0.032x
CoAsia Corporation
KQ:045970
0.073x
Courtside Group, Inc. Common Stock
NASDAQ:PODC
0.037x
AXON PARTNERS GRP EO -10
F:XE1
N/A
BIMobject AB
ST:BIM
-0.108x
Seoul Auction Co. Ltd
KQ:063170
0.048x
Cartier Resources Inc
V:ECR
0.000x
Korea Parts & Fasteners Co.Ltd
KQ:024880
0.085x

Annual Cash Flow Conversion Efficiency for Alterity Therapeutics Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Alterity Therapeutics Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ATH market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$42.40 Million
≈ $30.00 Million
AU$-11.45 Million
≈ $-8.10 Million
-0.270x +70.44%
2024-06-30 AU$13.80 Million
≈ $9.76 Million
AU$-12.61 Million
≈ $-8.92 Million
-0.914x -4.02%
2023-06-30 AU$22.81 Million
≈ $16.14 Million
AU$-20.04 Million
≈ $-14.18 Million
-0.878x -152.49%
2022-06-30 AU$35.47 Million
≈ $25.10 Million
AU$-12.34 Million
≈ $-8.73 Million
-0.348x +38.84%
2021-06-30 AU$30.47 Million
≈ $21.56 Million
AU$-17.33 Million
≈ $-12.26 Million
-0.569x +36.39%
2020-06-30 AU$10.55 Million
≈ $7.46 Million
AU$-9.43 Million
≈ $-6.67 Million
-0.894x -6.07%
2019-06-30 AU$16.55 Million
≈ $11.71 Million
AU$-13.95 Million
≈ $-9.87 Million
-0.843x -117.06%
2018-06-30 AU$16.08 Million
≈ $11.38 Million
AU$-6.25 Million
≈ $-4.42 Million
-0.388x -56.86%
2017-06-30 AU$23.69 Million
≈ $16.76 Million
AU$-5.87 Million
≈ $-4.15 Million
-0.248x -4.68%
2016-06-30 AU$31.37 Million
≈ $22.19 Million
AU$-7.42 Million
≈ $-5.25 Million
-0.237x +14.91%
2015-06-30 AU$39.11 Million
≈ $27.68 Million
AU$-10.87 Million
≈ $-7.69 Million
-0.278x +24.04%
2014-06-30 AU$37.69 Million
≈ $26.67 Million
AU$-13.79 Million
≈ $-9.76 Million
-0.366x +35.69%
2013-06-30 AU$13.97 Million
≈ $9.89 Million
AU$-7.95 Million
≈ $-5.63 Million
-0.569x +53.26%
2012-06-30 AU$5.62 Million
≈ $3.98 Million
AU$-6.85 Million
≈ $-4.84 Million
-1.217x -85.11%
2011-06-30 AU$6.93 Million
≈ $4.90 Million
AU$-4.56 Million
≈ $-3.23 Million
-0.658x +26.97%
2010-06-30 AU$5.23 Million
≈ $3.70 Million
AU$-4.71 Million
≈ $-3.33 Million
-0.900x +51.72%
2009-06-30 AU$3.75 Million
≈ $2.65 Million
AU$-6.99 Million
≈ $-4.95 Million
-1.865x -95.95%
2008-06-30 AU$9.89 Million
≈ $7.00 Million
AU$-9.41 Million
≈ $-6.66 Million
-0.952x +41.93%
2007-06-30 AU$5.61 Million
≈ $3.97 Million
AU$-9.20 Million
≈ $-6.51 Million
-1.639x -22.82%
2006-06-30 AU$8.73 Million
≈ $6.18 Million
AU$-11.66 Million
≈ $-8.25 Million
-1.335x -129.03%
2005-06-30 AU$19.51 Million
≈ $13.81 Million
AU$-11.37 Million
≈ $-8.05 Million
-0.583x -321.78%
2004-06-30 AU$38.47 Million
≈ $27.22 Million
AU$-5.31 Million
≈ $-3.76 Million
-0.138x +39.11%
2003-06-30 AU$15.78 Million
≈ $11.16 Million
AU$-3.58 Million
≈ $-2.53 Million
-0.227x -0.44%
2002-06-30 AU$16.68 Million
≈ $11.80 Million
AU$-3.77 Million
≈ $-2.67 Million
-0.226x --

About Alterity Therapeutics Ltd

AU:ATH Australia Biotechnology
Market Cap
$76.95 Million
AU$108.75 Million AUD
Market Cap Rank
#20212 Global
#693 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$0.17
About

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-… Read more